YABAO PHARM.CORP(600351.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
YABAO PHARM.CORP
600351.SH
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.
2.805 T
600351.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking55/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.02%B
    • Profit Margin14.53%B
    • Gross Margin53.24%B
  • Growth ScoreD
    • Revenue YoY-13.12%E
    • Net Profit YoY34.38%B
    • Total Assets YoY-8.14%E
    • Net Assets YoY-5.09%D
  • Cash ScoreC
    • Cash Flow Margin192.80%B
    • OCF YoY-13.12%E
  • Operating ScoreB
    • Turnover0.64B
  • Debt ScoreA
    • Gearing Ratio14.79%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    YABAO PHARM.CORP: Cumulatively spent 52.1519 million yuan to repurchase 1.14% of shares

    Zhitong·
    SH
    600351
    -1.52%
    Zhitong·
    SH
    600351
    -1.52%

    YABAO PHARM.CORP released its performance for the first three quarters, with a net profit attributable to the parent company of 215 million yuan, a year-on-year decrease of 8.44%

    Zhitong·
    SH
    600351
    -1.52%
    Zhitong·
    SH
    600351
    -1.52%

    YABAO PHARM.CORP: Sitagliptin Metformin Extended-Release Tablets have obtained the drug registration certificate

    Zhitong·
    SH
    600351
    -1.52%
    Zhitong·
    SH
    600351
    -1.52%

    YABAO PHARM.CORP disclosed the progress of its share repurchase, having repurchased a total of 6 million shares

    Zhitong·
    SH
    600351
    -1.52%
    Zhitong·
    SH
    600351
    -1.52%

    YABAO PHARM.CORP's controlling shareholder repurchased 13.65 million pledged shares in advance

    Zhitong·
    SH
    600351
    -1.52%
    Zhitong·
    SH
    600351
    -1.52%
    © 2026 Longbridge｜Disclaimer